샘플 요청 목록

 카트 문의
시장보고서
상품코드
2148470

인간 보조 생식 기술 시장

Human Reproductive Technologies
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 339 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,938,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 15,083,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,815,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 인간 보조 생식 기술 시장은 2032년까지 389억 달러에 달할 것으로 전망됩니다.

2025년 314억 달러로 추정되는 세계 인간 보조 생식 기술 시장은 2025년부터 2032년까지의 분석 기간 동안 연평균 성장률(CAGR) 3.1%를 기록하며 2032년까지 389억 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석 대상으로 삼고 있는 부문 중 하나인 ‘불임 치료 기술’은 연평균 성장률(CAGR) 3.7%를 기록하며, 분석 기간이 끝날 때까지 261억 달러에 달할 것으로 예측됩니다. ‘피임 기술’ 부문의 성장률은 분석 기간 동안 연평균 성장률(CAGR) 1.9%로 추정됩니다.

미국 시장은 85억 달러로 추산되는 반면, 중국은 연평균 성장률(CAGR) 5.6%를 나타낼 것으로 예측됩니다.

2025년 미국의 인간 보조 생식 기술 시장 규모는 85억 달러로 추산됩니다. 세계 2위의 경제 대국인 중국은 2025년부터 2032년까지의 분석 기간 동안 연평균 성장률(CAGR) 5.6%를 기록하며 2032년까지 시장 규모가 77억 달러에 달할 것으로 예측됩니다. 그 밖의 주목할 만한 지역 시장으로는 일본과 캐나다가 꼽히며, 분석 기간 동안 각각 연평균 성장률(CAGR) 1.4% 및 2.5%를 나타낼 것으로 예측됩니다. 유럽 내에서는 독일이 연평균 성장률(CAGR) 약 2.0%를 나타낼 것으로 예측됩니다.

세계 인간 보조 생식 기술 시장 - 주요 동향 및 촉진요인 개요

인간 보조 생식 기술 시장은 인구 동향의 변화, 기술 발전, 그리고 사회 규범의 변화가 맞물려 현저한 성장을 이루고 있습니다. 이 분야에는 불임 및 생식 관련 문제를 해결하기 위해 고안된 다양한 치료법과 기술이 포함되어 있으며, 불임률 상승과 가족 계획 시기가 늦어지는 추세와 같은 요인으로 인해 수요가 증가하고 있습니다. 생활 방식의 변화, 출산 시기 지연, 불임에 영향을 미치는 물질 섭취 증가 등의 요인이 불임 유병률 상승에 기여하고 있으며, 그 결과 생식 기술에 대한 의존도가 높아지고 있습니다. 의료의 진보로 인해 이러한 기술은 더욱 이용하기 쉬워지고 효과적이 되어 세계적으로 보급이 확대되고 있습니다. 특히 피임약 부문은 경구 피임약의 사용 편의성, 접근성, 투여의 간편함 덕분에 큰 시장 점유율을 차지하고 있으며, 원치 않는 임신 방지 및 성 건강 증진을 목표로 한 정부의 이니셔티브도 그 보급을 더욱 뒷받침하고 있습니다.

이 분야의 기술 혁신으로는 체외수정(IVF) 등의 인간 보조 생식 기술(ART)에서 현저한 진전이 나타나고 있습니다. ART에 대한 지적재산권(IP)의 통합, 특히 체외생식세포형성(IVG)과 같은 신기술과의 융합은 이 분야의 양상을 새롭게 바꾸고 있습니다. 세포를 재프로그래밍하여 정자나 난자로 발달시키는 IVG는 기존에는 달성할 수 없었던 유전자의 선택이나 변형을 가능하게 할 잠재력을 지니고 있어, 기존 방식으로부터의 큰 전환을 의미합니다. 이 분야의 지적 재산권에 대한 접근 방식은 협력적이고 개방적인 공유 모델에서 보다 경쟁적인 모델로 변화하고 있으며, 연구자와 기업들은 특허 확보를 점점 더 적극적으로 모색하고 있습니다. 이러한 변화는 IVG가 지닌 막대한 경제적 잠재력의 영향을 받고 있지만, 동시에 생식 기술 분야에서 특허 대상이 되는 소재의 범위와 실현 가능성에 영향을 미칠 수 있는 복잡한 윤리적·규제적 과제도 야기하고 있습니다.

인간 보조 생식 기술 시장의 확대는 몇 가지 주요 시장 성장 촉진요인에 의해 주도되고 있습니다. 세포질 내 정자 주입법(ICSI)이나 착상 전 유전자 진단(PGD)과 같은 혁신 기술은 불임 치료에 계속해서 혁명을 일으키며, 그 유효성을 높이고 매력을 확대되고 있습니다. ART(인간 보조 생식 기술)에 대한 사회적 수용도가 높아짐에 따라, 특히 ‘자발적인 한부모 가정’이나 LGBTQ+ 가족을 포함한 다양한 가족 구성에서 편견이 줄어들고 이용이 증가하고 있습니다. 또한, 의료 자금 조달 수단의 확대, 민간 투자 증가, 그리고 지원적인 법 개정을 통해 이러한 기술은 더욱 이용하기 쉬워졌으며, 보급이 확대되고 있습니다. 더불어 유전자 스크리닝의 발전과 맞춤형 의료의 추세로 인해, 더욱 세심하고 효과적인 불임 치료가 가능해졌습니다. 이러한 요인들이 복합적으로 작용하여, 생식 기술이 기능 면에서 진보할 뿐만 아니라 사회적 틀과 기대 속에 점점 더 통합되어 가는 역동적인 시장 환경이 조성되고 있으며, 이는 미래 세대가 어떻게 임신하고 태어나는지에 큰 영향을 미치고 있습니다.

부문:

기술(불임 치료 기술, 피임 기술), 성별(남성, 여성), 용도(불임 치료 클리닉, 병원·수술센터, 기타 용도)

주요 기업

  • Ansell Healthcare LLC
  • Ansell Ltd.
  • Apothecus Pharmaceutical Corporation
  • Bayer AG
  • Cipla Ltd.
  • Ferring Pharmaceuticals, Inc.
  • Indian Drugs &Pharmaceuticals Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Johnson &Johnson
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Mapa GmbH
  • Merck &Co., Inc.
  • Merck KGaA
  • Pfizer, Inc.
  • The Female Health Company（FC2）
  • T-MARC Tanzania

해당 분야의 전문가 관점을 바탕으로 합니다. 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착합니다 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용합니다-컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업 공시 정보, 연차 보고서, 기관지 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결합니다 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 수 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공합니다 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 관여하고 있는 기업을 상세하게 검증합니다.

주요 지역 시장 점유율을 면밀히 검토합니다 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구도는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞추어 상세도를 조정하여 주요 지역 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 26.10.28

Global Human Reproductive Technologies Market to Reach US$38.9 Billion by 2032

The global market for Human Reproductive Technologies estimated at US$31.4 Billion in the year 2025, is expected to reach US$38.9 Billion by 2032, growing at a CAGR of 3.1% over the analysis period 2025-2032. Infertility Treatment Technology, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$26.1 Billion by the end of the analysis period. Growth in the Contraceptive Technology segment is estimated at 1.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.5 Billion While China is Forecast to Grow at 5.6% CAGR

The Human Reproductive Technologies market in the U.S. is estimated at US$8.5 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$7.7 Billion by the year 2032 trailing a CAGR of 5.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Human Reproductive Technologies Market - Key Trends and Drivers Summarized

The human reproductive technologies market is experiencing substantial growth due to a confluence of demographic shifts, technological advancements, and evolving societal norms. This sector includes a variety of treatments and technologies designed to address fertility and reproduction challenges, with increasing demand driven by higher infertility rates and shifting trends towards later family planning. Factors such as lifestyle changes, delayed childbearing, and higher consumption of substances affecting fertility contribute to the growing prevalence of infertility, prompting greater reliance on reproductive technologies. Medical advancements are making these technologies more accessible and effective, enhancing their adoption across the globe. In particular, the contraceptive segment holds a significant market share due to the ease of use, widespread availability, and simple administration of oral contraceptives, further supported by government initiatives aimed at preventing unplanned pregnancies and promoting sexual health.

In terms of technological innovation within this sector, assistive reproductive technologies (ART) like in vitro fertilization (IVF) have seen notable developments. The integration of intellectual property (IP) into ART, especially with emerging technologies such as in vitro gametogenesis (IVG), is reshaping the landscape. IVG, which involves reprogramming cells to develop into sperm or eggs, represents a significant shift from traditional methods by potentially allowing genetic selection and modification previously unattainable. The approach to IP in this realm has evolved from a collaborative, open-sharing model to a more competitive one, with researchers and companies increasingly seeking to secure patents. This shift is influenced by the substantial financial potential of IVG, although it also brings complex ethical and regulatory challenges that could affect the scope and viability of patentable material in reproductive technologies.

The expansion of the human reproductive technologies market is propelled by several key drivers. Innovations such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD) continue to revolutionize fertility treatments, enhancing their effectiveness and broadening their appeal. The growing societal acceptance of ART has reduced stigma and increased usage, particularly among diverse family structures, including single parents by choice and LGBTQ+ families. Additionally, the expansion of healthcare financing options, increased commercial investments, and supportive legislative changes have made these technologies more accessible and popular. Moreover, advancements in genetic screening and the trend toward personalized medicine are enabling more tailored and effective fertility treatments. Collectively, these factors are fostering a dynamic market environment where reproductive technologies are not only advancing in capability but also becoming more integrated into societal frameworks and expectations, significantly impacting how future generations are conceived and born.

SCOPE OF STUDY:

The report analyzes the Human Reproductive Technologies market by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Infertility Treatment Technology, Contraceptive Technology); Gender (Male Gender, Female Gender); End-Use (Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Ansell Healthcare LLC
  • Ansell Ltd.
  • Apothecus Pharmaceutical Corporation
  • Bayer AG
  • Cipla Ltd.
  • Ferring Pharmaceuticals, Inc.
  • Indian Drugs & Pharmaceuticals Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Mapa GmbH
  • Merck & Co., Inc.
  • Merck KGaA
  • Pfizer, Inc.
  • The Female Health Company (FC2)
  • T-MARC Tanzania

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Human Reproductive Technologies - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 12 Players Worldwide in 2026 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Infertility Rates Propel Growth for Human Reproductive Technologies
    • Advancements in Assisted Reproductive Technology (ART) Expands Addressable Market Opportunity
    • Increasing Awareness and Acceptance of IVF Throws the Spotlight on Market Growth
    • Technological Innovations in Cryopreservation Drives Demand for Fertility Preservation
    • Regenerative Medicine and Stem Cell Research Strengthens Business Case for Novel Therapies
    • Genetic Screening and Diagnostic Innovations Generate Accelerated Demand
    • Here's the Story on the Market Impact Rising Age of First-Time Parenthood
    • Improved Success Rates of Fertility Treatments Sustains Growth in the Market
    • Telemedicine Integration Drives Adoption of Reproductive Health Services
    • Regulatory Approvals and Ethical Issues Impact Market Dynamics
    • Here's How Personalized Medicine and Precision Fertility Enhance Treatment Efficacy
    • Advancements in Non-Invasive Diagnostic Techniques Drives Market Adoption
    • Environmental and Occupational Factors Propel Growth in Fertility Solutions Market
    • Increasing Focus on Male Infertility Solutions Expands Market Opportunity
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 2: World Historic Review for Human Reproductive Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 3: World 13-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 4: World Human Reproductive Technologies Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Infertility Treatment Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Infertility Treatment Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Infertility Treatment Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Contraceptive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Contraceptive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Contraceptive Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Male Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Female Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Fertility Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Hospitals & Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Hospitals & Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 27: USA Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: USA 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 29: USA Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 30: USA Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: USA 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 32: USA Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 33: USA Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: USA 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 36: Canada Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: Canada 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Canada Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: Canada 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 42: Canada Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: Canada 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • JAPAN
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: Japan Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: Japan 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: Japan Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: Japan 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Japan Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: Japan 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CHINA
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: China Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: China 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 56: China Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: China Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: China 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 59: China Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: China Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: China 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • EUROPE
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 63: Europe Historic Review for Human Reproductive Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: Europe 13-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Europe Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: Europe 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Europe Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: Europe 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Europe Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: Europe 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • FRANCE
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 75: France Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: France 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 77: France Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 78: France Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: France 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 80: France Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: France Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: France 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • GERMANY
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Germany Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: Germany 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Germany Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: Germany 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Germany Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: Germany 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Italy Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: Italy 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Italy Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: Italy 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Italy Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Italy 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: UK Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: UK 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 104: UK Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: UK Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: UK 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 107: UK Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: UK Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: UK 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Spain Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: Spain 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Spain Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: Spain 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Spain Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: Spain 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Russia Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: Russia 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Russia Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Russia 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Russia Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Russia 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Rest of Europe 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Rest of Europe 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Rest of Europe 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Human Reproductive Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Asia-Pacific 13-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Asia-Pacific 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Asia-Pacific 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: Asia-Pacific 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Australia Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: Australia 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Australia Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: Australia 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Australia Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: Australia 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • INDIA
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: India Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: India 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 161: India Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: India Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: India 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 164: India Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: India Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: India 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: South Korea Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: South Korea 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: South Korea Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: South Korea 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: South Korea Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: South Korea 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 186: Latin America Historic Review for Human Reproductive Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: Latin America 13-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Latin America Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: Latin America 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Latin America Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Latin America 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Latin America Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Latin America 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Argentina Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Argentina 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Argentina Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Argentina 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Argentina Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Argentina 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Brazil Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Brazil 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Brazil Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Brazil 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Brazil Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Brazil 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Mexico Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Mexico 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Mexico Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Mexico 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Mexico Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: Mexico 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: Rest of Latin America 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: Rest of Latin America 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: Rest of Latin America 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 234: Middle East Historic Review for Human Reproductive Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: Middle East 13-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: Middle East Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: Middle East 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Middle East Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Middle East 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Middle East Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Middle East 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Iran Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Iran 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Iran Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Iran 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Iran Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Iran 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Israel Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Israel 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Israel Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Israel 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Israel Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Israel 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Saudi Arabia 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Saudi Arabia 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Saudi Arabia 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: UAE Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: UAE 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: UAE Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: UAE 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: UAE Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: UAE 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: Rest of Middle East 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: Rest of Middle East 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: Rest of Middle East 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AFRICA
    • Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Africa Historic Review for Human Reproductive Technologies by Technology - Infertility Treatment Technology and Contraceptive Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: Africa 13-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Infertility Treatment Technology and Contraceptive Technology for the Years 2020, 2026 & 2032
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Human Reproductive Technologies by Gender - Male Gender and Female Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Africa Historic Review for Human Reproductive Technologies by Gender - Male Gender and Female Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Africa 13-Year Perspective for Human Reproductive Technologies by Gender - Percentage Breakdown of Value Sales for Male Gender and Female Gender for the Years 2020, 2026 & 2032
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Africa Historic Review for Human Reproductive Technologies by End-Use - Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Africa 13-Year Perspective for Human Reproductive Technologies by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics End-Use, Hospitals & Surgery Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기